Rise in Research Funding to Aid the Stem Cells Market over the Next Five Years
Albany, NY (PRWEB) February 05, 2015 -- The research report segments the global stem cells market on the basis of type, therapeutic area, and technology. By type, stem cells are divided into embryonic stem cells, cord blood stem cells, adult stem cells, and others. By therapeutic application area, the stem cells market is categorized into orthopedics, diabetes, cardiology, hepatology, neurology, hematology, oncology, and dermatology. On the basis of technology, cord blood banking, xenotransplantation, stem cell transplantation, and CB genomics are the main sub segments. The research report studies each segment and offers unbiased and in-depth analyses of each. Key profitable areas and slow-growth segments are highlighted and discussed, and recommendations for improvement are offered.
View Full Report at http://www.marketresearchreports.biz/analysis/227569
Geographically, the stem cells market is categorized into four primary regions: North America, Europe, Asia-Pacific, and Rest of the World. The report provides global market estimations as well as predictions for each region till 2020. With the help of graphical representations, the report offers the industry shares and investment figures for individual geographic regions within the stem cells market.
While discussing the U.S. market for stem cells as part of the larger North America market, the report talks about the role and contribution of the National Institutes of Health (NIH), backing from the U.S. government for stem cell research, human embryonic stem cells development and its setbacks, the first FDA-approved human clinical trial of stem cell therapy, and issues regarding NIH funding with respect to embryonic stem cell research. The report also provides an exhaustive list of stem cell banks in the U.S.
Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/227569
The research report divides the Europe stem cells market into Spain, Germany, Sweden, United Kingdom, Russia, France, Switzerland, and Rest of Europe. The list of embryonic stem cell banks, cord blood stem cell banks, and adult stem cell banks are presented in a graphical format and market figures for the years 2010 and 2015, and estimations for 2020 are provided.
Segmenting the Asia-Pacific stem cells market into India, China, Australia, Japan, South Korea, and Rest of Asia-Pacific, the report discusses the stem cells sector, identifying key industry leaders. The South Korea market for stem cells is particularly highlighted, owing to the presence of many stem cell banks and drugs and continuing support from the President. The stem cell drugs and banks profiled in the research report are KRIBB, CARTISTEM, Chaum Life Center, National Stem Cell Bank, and Hearticellgram-AMI. CARTISTEM – the first approved stem cell drug in the world for degenerative arthritis – enjoys special mention in the research report.
The Rest of the World region includes the Middle East, Latin America, and South Africa and the research report lists out the major players operating within the stem cells market.
About MarketResearchReports.biz:
Marketresearchreports.biz ( http://www.marketresearchreports.biz/ ) is the most comprehensive collection of market research reports, supporting clients’ market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profits in its repository. We also offer consulting support for custom market research needs.
Our document database is updated by the hour, which means that our customers always have access to fresh data spanning over 300 industries. From Fortune 500 companies to SMEs, Marketresearchreports.biz has built a veritable reputation for fulfilling the most exacting market research needs.
Contact:
Atil Chuadhari
State Tower
90 State Street,
Suite 700, Albany
NY 12207, United States
Toll Free: 866-997-4948
Email: sales(at)marketresearchreports(dot)biz
Michell Thoras, Market Research Reports, http://www.marketresearchreports.biz/, +1 (518) 618-1030, [email protected]
Share this article